The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.

Northwind Pharmaceuticals, a rapidly growing national provider of prescription medications, chronic care programs, and pharmacy benefits, adds former Marathon Health CEO Jerry Ford to its strategic advisory board.

The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human heart models

In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug delivery methods in over a century.

Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions.

The appointment further strengthens the company's scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria's approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders.

AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics

Effective for Lowering Blood Sugar Plus Appeal of 1x-Month Injection and Potential Slimming

Hashtag Added to Ozempic Medication for TikTok Viewers Pushing Ongoing Shortage

•• Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone
•• NEXAGON was well-tolerated demonstrating a safety profile similar to vehicle
•• Amber plans to initiate the NEXPEDE-1 Phase 2/3 clinical trial in subjects with PCED of various etiologies in Q1 2023 ••

Stage Analytics commits to focused growth in Health Economics and Outcomes Research (HEOR), Legal Services, Innovation and Education, and Project Management Services

The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers

Gb Sciences' innovative approach harnesses the power of plant-based treatments as simplified mixtures that target dangerous hyperinflammatory responses to viral infections.

New Integration Delivers 52% Cost Savings and 88% Time Savings in Computational Execution with GPU-accelerated Industry-Standard Tools

As mental health disorders increasingly impact global populations, Gb Sciences is developing psychotropic but non-psychedelic treatments for anxiety and depression that compete with the emerging billion-dollar psychedelic companies.

Aronora co-founder and CEO Dr. Erik Tucker has been elected as Fellow of the National Academy of Inventors (NAI)

Presentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation

One of the major barriers to accessing medical marijuana's Australia wide is the cost but experts say the industry is evolving with more local production set to bring prices down.

Last year, the number of Australians taking medicinal cannabis surpassed 100,000. As access to the treatment gets easier, patient demand continues to skyrocket.

P23 Labs, a leading molecular laboratory, is kicking off its 23 Days of Giving series of charitable events running from Dec. 1 to Dec. 23, 2022. Three of these days will be dedicated to gifts to the company's team members and 20 days are for charitable donations to causes from P23 and its partner, Laddia Whittier, who made a generous contribution to make this initiative possible.

Next-generation proteomics technology made available to the biotech and pharmaceutical industry through the acquisition of Methuselah Health by leading R&D services provider, RxCelerate

State-of-the-art system of neural networks and machine learning models that transforms non-numeric healthcare provider voice responses at scale into measurable insights.

Employees allege firing after religious exemptions to covid shot mandate were denied

Coming in overall at 125th, Apprentice is recognized for its 1,159% revenue growth as it continues to scale its Tempo Manufacturing Cloud platform for Life Sciences.

Expert life science compliance consulting firm TRESTLE Compliance partners with qordata to leverage TRESTLE's compliance expertise and qordata's compliance management tools to provide life science innovators comprehensive compliance solutions that mitigate risks and maximize effectiveness.

Updated capabilities and continued growth reflect the brand's modern approach to life sciences manufacturing

As published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation.

At the Annual Summit, Dr. Andrea Small-Howard is presenting a Keynote Address that includes data from case studies demonstrating the utility of Gb Sciences' proprietary PhAROS drug discovery platform.

Clinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators

Gb Sciences' anxiety formulations were previously identified using the company's AI-driven PhAROS™ platform, and they have now been evaluated using preclinical zebrafish models of stress at the National Research Council of Canada.

The Optejet® ophthalmic drug device is designed to precisely administer medication to the eye, potentially treating patients' conditions through gentler, more efficient dosing.

Dr. Andrea Small-Howard discusses the company's novel process for developing disease-specific, cannabinoid-based therapeutics.

Hurricane Ian's Impact on Direct-to-Consumer Pharmaceutical Fulfillment Exacerbates an Already Vexing Challenge.

Ambit to showcase its prevalence projection approach, co-developed with Praxis, for rare developmental and epileptic encephalopathies (DEEs) as a Platform Presentation at this year's annual Child Neurology Society meeting

Recognition further commits CBD manufacturer to compliance across multiple industries

As published in Frontiers in Pharmacology, the biopharmaceutical drug development firm's sponsored research has identified and validated cannabinoid ratio-controlled, Minimum Essential Mixtures (MEM) for the treatment of Parkinson's disease symptoms

Sitero launches Biosafety Consulting Services offering

Entrepreneur-eye surgeon continues his family's legacy in the field of ophthalmology, as Eyenovia's new Chairman

Effectively Addressing Risk of Stroke, Embolisms, and Deep Vein Thrombosis with Medication

Stirling provides healthcare practitioners with the industry's most powerful and trusted lotions, gels and balms to help alleviate joint pain.

Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of therapeutic classes.

TranspareRx will soon launch Cuverd - The Next-Generation Prescription Savings Platform and App

Ozempics Continuing to Stand Out as a New Type 2 Diabetes Medication Alternative